Formac Pharmaceuticals
0892.914.395 · rovalta.com · 24/09/2026
ACTIVE
Formac Pharmaceuticals
Financial year 2025 · Closed on 31/12/2025
Net result
1,6 k €
+105,6 %over 1 yearGross margin
2,6 k €
-98,2 %over 1 yearEquity
2,1 k €
+331,5 %over 1 yearWorkforce
0,0 ETP
Overview
Identity
Source · BCE/KBOFormac Pharmaceuticals is a Public limited company incorporated in 2007. Its registered office is in Leuven.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0892.914.395
- Incorporation
- 03/10/2007
- Legal form
- Public limited company
- Registered office
- Gaston Geenslaan 1
3001 Leuven · FlandreSee on map - Contributed capital
- 6 887 603,08 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,0 ETP
Joint committees (1)
- 207
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA
Financials
Source · NBB, 18 filingsTrend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 2,6 k € | -98.2% | 145,6 k € | +2255% | -6,8 k € | -72.9% | -3,9 k € | +41.8% | -6,7 k € |
| EBITDA | 1,8 k € | +106% | -28,7 k € | -323% | -6,8 k € | -73.3% | -3,9 k € | +44.7% | -7,1 k € |
| Operating result | 1,8 k € | +106% | -28,7 k € | +76.8% | -123,5 k € | -1.5% | -121,7 k € | +3.1% | -125,6 k € |
| Net result | 1,6 k € | +106% | -28,9 k € | +78.2% | -132,5 k € | -1.7% | -130,3 k € | +2.5% | -133,6 k € |
| Balance sheet | |||||||||
| Equity | 2,1 k € | +331% | 489,4 € | -98.3% | 29,4 k € | -81.9% | 161,9 k € | -44.6% | 292,2 k € |
| Total assets | 2,1 k € | +331% | 489,4 € | -99.7% | 185,6 k € | -40.2% | 310,1 k € | -28.9% | 435,9 k € |
| Cash | 1,8 k € | +772% | 210,5 € | -95.4% | 4,6 k € | -57.7% | 10,9 k € | -44.0% | 19,4 k € |
| Debts | – | 0 € | -100% | 101 k € | -0.8% | 101,7 k € | +0.2% | 101,5 k € | |
| Other | |||||||||
| Workforce | 0,0 ETP | 0,0 ETP | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20253 active · 46 ended
Active mandates
Ivo Roelants
ActiveJohan Martens
ActiveRudi Cuyvers
ActiveEnded mandates
Ivo Roelandts
EndedIvo Roelandts
EndedIvo Roelandts
EndedJohan Martens
EndedOther companies at this address
Gaston Geenslaan 1 3001 Leuven| Company | CBE no. |
|---|---|
ALIGOS BELGIUM● Active | 0702.969.886 |
Bio-Incubator Leuven● Active | 0876.605.232 |
Community Building Arenberg● Active | 1014.096.594 |
Creative Biolabs Belgium● Active | 1028.942.544 |
DName-iT● Active | 0506.754.823 |
Fisherman● Active | 0804.287.079 |
Fishway● Active | 0787.869.632 |
IDA INTERNATIONAL● Active | 1002.119.470 |
Lever Bio Belgium● Active | 1039.455.958 |
Maatschap reMYND● Active | 1019.655.090 |
miDiagnostics● Active | 0641.984.602 |
Oxurion● Active | 0881.620.924 |
PALEO● Active | 0756.986.614 |
PARKEERGEBOUW● Active | 1009.039.728 |
Pledge Therapeutics● Active | 0726.743.301 |
Qmineral● Active | 0837.633.897 |
Raya Therapeutic● Active | 1003.128.171 |
ReGenesys● Active | 0877.070.337 |
ReGenesys EU● Active | 0544.577.301 |
reMYND● Active | 0476.910.101 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/07/2026 | 22/07/2025 | 01/08/2024 | 18/07/2023 | 12/07/2022 | 16/07/2021 |
| General meeting | 26/06/2026 | 27/06/2025 | 28/06/2024 | 30/06/2023 | 27/06/2022 | 23/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 18 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 26/06/2026 | 31/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 27/06/2025 | 22/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 28/06/2024 | 01/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 18/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 27/06/2022 | 12/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 23/06/2021 | 16/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 25/06/2020 | 30/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 25/06/2019 | 25/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 28/06/2018 | 30/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 23/06/2017 | 24/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/06/2016 | 18/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 28/05/2015 | 01/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 28/05/2014 | 27/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 27/06/2013 | 05/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 02/05/2012 | 01/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 20/04/2011 | 29/04/2011 | Dutch | |
| Abridged model | 31/12/2009 | 21/04/2010 | 02/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 08/04/2009 | 04/05/2009 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 46 ended
Active mandates
Ivo Roelants
ActiveJohan Martens
ActiveRudi Cuyvers
ActiveEnded mandates
Ivo Roelandts
EndedIvo Roelandts
EndedIvo Roelandts
EndedJohan Martens
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates02/08/2017Mededeling - Ontslag & herbenoeming bestuurders en ontslag algemeen :
- Capital / shares25/06/2015KAPITAALVERHOGING - STATUTENWIJZIGING - UITGIFTE WARRANTS
- Mandates04/07/2014(Bevestiging) ontslag en benoeming bestuurders en waarnemers
- Mandates15/07/2013Mededeling - Ontslag benoeming bestuurder
- Mandates08/03/2012KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares21/12/2011KAPITAAL - AANDELEN
- Mandates28/11/2011KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares12/08/2010KAPITAAL - AANDELEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,6 k €↑
- 2024Annual accounts 2024-28,9 k €↑
- 2023Annual accounts 2023-132,5 k €↓
- 2022Annual accounts 2022-130,3 k €↑
- 2021Annual accounts 2021-133,6 k €↑
- 2013Annual accounts 2013-924,2 k €↓
- 2012Annual accounts 2012-916,7 k €↑
- 2011Annual accounts 2011-1,5 M €↓
- 2009Annual accounts 2009-831 k €↓
- 2008Annual accounts 2008-444,3 k €
- 03/10/2007IncorporationPublic limited company